Jämför metoder
Granska de valda metoderna sida vid sida; rader som skiljer sig är markerade.
| Borderline Symptom List (BSL-95)× | Young Mania Rating Scale (YMRS)× | |
|---|---|---|
| Ämnesområde | Psykiatri | Psykiatri |
| Familj | Process / pipeline | Process / pipeline |
| Ursprungsår≠ | 2007 | 1978 |
| Upphovsperson≠ | Martin Bohus | Robert C. Young |
| Typ≠ | Self-report questionnaire | Clinician-administered rating scale |
| Ursprungskälla≠ | Bohus, M., Kleindienst, N., Limberger, M. F., Stieglitz, R. D., Domsalla, M. E., Chapman, A. L., ... & Wolf, M. (2009). The short version of the Borderline Symptom List (BSL-23): Development and initial data on psychometric properties. Psychopathology, 42(1), 32–39. DOI ↗ | Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: Reliability, validity and sensitivity. British Journal of Psychiatry, 133(5), 429–435. DOI ↗ |
| Alias≠ | BSL, BSL-95, Borderline Symptom List-95 | YMRS |
| Närliggande | 3 | 3 |
| Sammanfattning≠ | The BSL-95 is a 95-item self-report questionnaire designed to measure the severity of borderline personality disorder (BPD) symptoms across nine subscales: affect dysregulation, distrust, self-harming behaviors, suicide risk, identity disturbance, negative relationships, and dissociation. Developed by Bohus and colleagues in 2007, it provides comprehensive assessment of the multifaceted psychopathology of BPD. A brief 23-item version (BSL-23) has also been validated for rapid assessment. The BSL is sensitive to treatment effects and widely used in BPD research and clinical monitoring. | The YMRS is an 11-item clinician-administered rating scale designed to assess the severity of manic and hypomanic symptoms in bipolar disorder. Developed by Young and colleagues in 1978, it is the gold standard outcome measure in bipolar disorder research and the primary efficacy endpoint in mood stabilizer and antipsychotic trials for acute mania. The YMRS captures core mania features (elevated mood, increased goal-directed activity, racing thoughts, reduced need for sleep, increased talkativeness, distractibility, and irritability) and is sensitive to both pharmacological and psychotherapeutic interventions. |
| ScholarGateDatamängd ↗ |
|
|